Accession Number: | 0001593968-22-001122 |
Date: | 2022-06-09 |
Issuer: | SILK ROAD MEDICAL INC (SILK) |
Original Submission Date: |
BALLINGER KEVIN J.
1213 INNSBRUCK DRIVE
SUNNYVALE, CA 94089
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-06-09 | A | 846 | a | $0.00 | 1,416 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 36.9 | 2022-06-09 | deemed execution date | A | 3,214 (a) | 2022-09-05 | 2032-06-09 | common stock 3,214 | $36.90 | 3,214 | direct | |
OPTION (RIGHT TO BUY) | 36.9 | 2022-06-09 | deemed execution date | A | 5,195 (a) | 2023-06-05 | 2032-06-09 | common stock 5,195 | $36.90 | 5,195 | direct |
ID | footnote |
---|---|
f1 | the reported securities are represented by restricted stock units ("rsus"), each of which represents a contingent right to receive one share of silk common stock. all of the rsus vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the issuer's 2023 annual meeting of stockholders, subject to the reporting person continuing as a service provider through each such date. |
f2 | the shares subject to the options represent cash retainer that the reporting person elected to receive in the form of stock options. |
f3 | one fourth of the shares subject to the option shall vest on each of september 5, 2022, december 5, 2022, march 5, 2023, and the date of the issuer's 2023 annual meeting of stockholders, subject to the reporting person continuing as a service provider through each such date. |
f4 | all of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the issuer's 2023 annual meeting of stockholders, subject to the reporting person continuing as a service provider through each such date. |